Researchers analyze dynamic changes in chest CT images over 167 days in 11 COVID-19 patients

Announcing a new article publication for Zoonoses journal. In this article the authors Jianqin Liang, Guizeng Liu, Shuzhuang Yu, Yang Yang, Yanchun Li, Hongli Tian, Zhe Chen and Wenping Gong The Eighth Medical Center of PLA General Hospital, Beijing, China and Nanpi County People's Hospital, Hebei, China discuss dynamic changes in chest CT images over 167 days in 11 patients with COVID-19.

Studies have shown that patients still have at least one persistent symptom six months after the onset of disease. The most common symptoms are fatigue, muscle weakness, sleep disturbance, anxiety and depression. Recently, CT findings have been widely reported to be associated with the clinical severity of COVID-19. However, the correlation between CT findings of COVID-19 patients and long-term results is unclear. In this article the authors conducted a 167-day long-term follow-up on the CT results of 11 COVID-19 patients to assess the long-term prognosis of 11 COVID-19 patients.

The data indicates that chest CT can enable early detection of COVID-19 and determination of the different stages of COVID-19. Furthermore, mild cases tend to have better prognosis, whereas severe cases still showed cord-like fibrosis in the lungs in follow-up at the 167th day after symptom onset.

Source:
Journal reference:

Liang, J., et al. (2021) Dynamic Changes in Chest CT Images Over 167 Days in 11 Patients with COVID-19: A Case Series and Literature Review. Zoonoses. doi.org/10.1007/s11604-020-01037-w.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Phase 2 study evaluates safety and efficacy of asunercept in COVID-19 patients